Albany, NY -- (SBWIRE) -- 12/21/2017 -- According to the research report, the global diabetes drugs market was valued at US$43.1 bn in 2016 at is expected to be worth US$58.4 bn by the end of 2025. During the forecast years of 2017 and 2025, the global market is expected to surge at a CAGR of 3.6%.

The Global Diabetes Drugs market is segmented on the basis of Therapy, Disease Type, Distribution Channel and Geography.

The diabetes drugs market is classified on the basis of therapy type, disease type, distribution channels, and region. Based on the therapy type, the market is divided into glucagon-like peptide-1 (GLP-1) agonist, Dipeptidyl-peptidase-4 (DPP-4) inhibitors, sodium glucose co-transporter 2 (SGLT2) inhibitors, Insulin and others. Based on distribution channel, the market has been categorized into hospital pharmacies, retail pharmacies, and online pharmacies. Out of these distribution channels, hospitals pharmacies held a leading share in the global market due to availability of trained staff to sell medicines. Analysts expect that online pharmacies are also expected to show remarkable progress in the near future due to emergence of e-commerce and growing number of tech-savvy consumers.

Read Report Overview @ https://www.transparencymarketresearch.com/diabetes-drug-market.html

Geographically, the diabetes drugs market has been segmented into 5 major regions, which are North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America accounted for the highest revenue in 2016, due to high prevalence of diabetes in the region. Europe is anticipated to hold second large market share in 2016 owing to increasing investment in research & development and promising pipeline of diabetes drugs in Europe. Asia Pacific is expected to grow fast, owing to the increasing awareness and promotion in the region. Middle East & Africa is anticipated to grow during the forecast period due to increasing prevalence of diabetes and growing disposable income especially in Middle East countries in the region. Latin America is expected to grow during the forecast period owing to overdependence of physicians and patients on insulin.

Request Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=14672

Summary of Table of Content

1. Preface
2. Assumptions and Research Methodology
3. Executive Summary: Global Diabetes Drugs Market
4. Market Overview
5. Global Diabetes Drugs Market Analysis and Forecasts, By Therapy
6. Global Diabetes Drugs Market Analysis and Forecasts, By Disease Type
7. Global Diabetes Drugs Market Analysis and Forecasts, By Distribution Channel
8. Global Diabetes Drugs Market Analysis and Forecasts, By Region
9. North America Diabetes Drugs Market Analysis and Forecast
10. Europe Diabetes Drugs Market Analysis and Forecast
11. Asia Pacific Diabetes Drugs Market Analysis and Forecast
12. Middle East & Africa Diabetes Drugs Market Analysis and Forecast
13. Latin America Diabetes Drugs Market Analysis and Forecast
14. Competition Landscape

Request to Browse Full Table of Content, figure and Tables @ https://www.transparencymarketresearch.com/report-toc/14672